- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
PharmaEngine
Market Cap: NT$13.0b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$90.30
7D
-2.3%
1Y
-0.3%
TTY Biopharm
Market Cap: NT$18.7b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$75.20
7D
0.1%
1Y
-3.1%
Lotus Pharmaceutical
Market Cap: NT$61.5b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$234.50
7D
3.3%
1Y
-17.4%